Central Trust Company’s Arvinas ARVN Stock Holding History

Central Trust Company’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	–	–	1298
2022 Q2	$0	Hold	6	–	–	﹤0.01%	1359
2022 Q1	$0	Buy	+6	New	+$409	﹤0.01%	1340

Other funds holding ARVN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Central Trust Company's ARVN Position: Q3 2022 in Review

Central Trust Company sold out of Arvinas (ARVN) in Q3 2022, closing a stake of 6 shares.

Central Trust Company first reported a position in ARVN in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 175 funds tracked by Wall St. Rank hold ARVN as of Q3 2022.

Central Trust Company reported no remaining Arvinas position as of Q3 2022 after selling out during the quarter.
Central Trust Company sold 6 Arvinas shares in Q3 2022.
Central Trust Company first reported a position in Arvinas in Q1 2022 and held it in 2 quarters.
Central Trust Company's Arvinas position peaked at $0 in Q2 2022.
175 funds tracked by Wall St. Rank held Arvinas as of Q3 2022.

Based on Central Trust Company's 13F filing for Q3 2022, filed 3 Nov 2022.